Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Halfon

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Journal of Medical Virology|December 16, 2011
Multicenter assessment of HIV-1 RNA quantitation in semen in the CREAThE networkChristophe Pasquier, Corinne Andreutti, Evelyne Bertrand, et al.
Medicine|June 4, 2016
Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven GlomerulonephritisPierre-Andre Jarrot, Laurent Chiche, Baptiste Hervier, et al.
European Journal of Gastroenterology & Hepatology|June 21, 2019
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patientsArmand Garioud, Ratmony Heng, Xavier Amiot, et al.
Antiviral Therapy|July 22, 2017
Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohortPhilippe Halfon, Caroline Scholtès, Jacques Izopet, et al.
Journal of Clinical Microbiology|October 6, 2006
Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter studySyria Laperche, Vincent Thibault, Françoise Bouchardeau, et al.
Therapeutic Advances in Chronic Disease|July 31, 2020
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibitionEloïne Bestion, Zuzana Macek Jilkova, Jean-Louis Mège, et al.
The American Journal of Gastroenterology|March 18, 2006
Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca studyPhilippe Halfon, Marc Bourliere, Romaric Deydier, et al.
Autophagy|November 6, 2021
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functionsSonia Brun, Eloïne Bestion, Eric Raymond, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2018
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in EuropeCleo Keppens, John F Palma, Partha M Das, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2024
Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in FranceJean-François D Cadranel, Honoré T Zougmoré, Jean-René Ngele Efole, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Journal of Medical Virology|December 16, 2011
Multicenter assessment of HIV-1 RNA quantitation in semen in the CREAThE networkChristophe Pasquier, Corinne Andreutti, Evelyne Bertrand, et al.
Medicine|June 4, 2016
Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven GlomerulonephritisPierre-Andre Jarrot, Laurent Chiche, Baptiste Hervier, et al.
European Journal of Gastroenterology & Hepatology|June 21, 2019
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patientsArmand Garioud, Ratmony Heng, Xavier Amiot, et al.
Antiviral Therapy|July 22, 2017
Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohortPhilippe Halfon, Caroline Scholtès, Jacques Izopet, et al.
Journal of Clinical Microbiology|October 6, 2006
Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter studySyria Laperche, Vincent Thibault, Françoise Bouchardeau, et al.
Therapeutic Advances in Chronic Disease|July 31, 2020
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibitionEloïne Bestion, Zuzana Macek Jilkova, Jean-Louis Mège, et al.
The American Journal of Gastroenterology|March 18, 2006
Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca studyPhilippe Halfon, Marc Bourliere, Romaric Deydier, et al.
Autophagy|November 6, 2021
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functionsSonia Brun, Eloïne Bestion, Eric Raymond, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2018
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in EuropeCleo Keppens, John F Palma, Partha M Das, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2024
Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in FranceJean-François D Cadranel, Honoré T Zougmoré, Jean-René Ngele Efole, et al.
Pageof 16